Emory University has won a patent fight with a defunct metro Atlanta biomedical firm and a former corporate officer who is now serving a federal prison sentence for securities fraud.

In an order handed down July 24, U.S. District Judge Thomas W. Thrash Jr. granted Emory’s motion for summary judgment in the case. In doing so, Thrash upheld patents that Emory has secured over the past decade for an anti-microbial agent impervious to water that can shield hard surfaces from contamination by weapons-grade biological viruses and bacteria.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]